Tag Archives: Mylan

Generic drug maker Mylan pulls a mini-Pfizer tax inversion

Posted on July 15, 2014 by Alexander Szewczak

Taking a page from Pfizer’s playbook, Mylan is buying Abbott Laboratories’ branded specialty and generics businesses in developed markets outside the U.S..  The $5B deal is structured to result in a tax inversion, with the newly formed merged company to be headquartered in the Netherlands. “We see … Continue reading →

Posted in Pharmaceutical Industry | Tagged , , , | 1 Comment